The pharmaceutical giant will invest $1 billion in a Delaware plant to manufacture Keytruda, as drugmakers ramp up U.S.

Germany's Merck KGaA has struck a deal to buy U.S. biotech company SpringWorks Therapeutics for an equity value of $3.9 ...

Merck is investing $1 billion to build a U.S. plant in Delaware, in a show of its commitment to domestic manufacturing.

The firm reported revenues of $15.53 billion and adjusted earnings per share of $2.22, surpassing consensus predictions of ...

Germany's Merck is on the verge of a billion-euro takeover of US biopharmaceutical company Springworks Therapeutics, with the ...

EQS-Adhoc: Merck KGaA: Merck confirms late-stage discussions with SpringWorks Therapeutics, Inc. on potential acquisition ...

Over the past five years, the stock has recorded a negative one-day return in 65% of cases, with a median decline of -2.4% ...

Omar M. Abuattieh, a student attending the Ernest Mario School of Pharmacy at Rutgers University-New Brunswick, has been ...

The pharmaceutical industry faces environmental challenges. Green chemistry offers sustainable solutions to reduce waste and ...

Renée Slegers has made five changes to our squad as we prepare to face Leicester City in the Barclays Women’s Super League. Stina Blackstenius starts up top with Alessia Russo missing through injury, ...

The full back makes his first league start for us since May 2023, and is joined in the team by Oleksandr Zinchenko, Leandro Trossard, Jorginho and Ethan Nwaneri. The five to miss out from the midweek ...